GenVec sells IPO

Gene therapy company GenVec (GNVC) raised $38 million through the sale of 4 million shares at $9.50 in an IPO underwritten by J.P. Morgan; UBS Warburg; and A.G. Edwards. On Monday, GNVC reduced the pr...